相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Duchenne muscular dystrophy
Dongsheng Duan et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning
Anat Mirelman et al.
MOVEMENT DISORDERS (2021)
Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center
Jessica R. Marden et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2020)
Suitability of external controls for drug evaluation in Duchenne muscular dystrophy
Nathalie Goemans et al.
NEUROLOGY (2020)
Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaboration
Nathalie Goemans et al.
PLOS ONE (2020)
Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy
Anne M. Connolly et al.
MUSCLE & NERVE (2019)
Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy
Francesco Muntoni et al.
PLOS ONE (2019)
Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
Craig M. McDonald et al.
LANCET (2018)
Rehabilitation Management of the Patient With Duchenne Muscular Dystrophy
Laura E. Case et al.
PEDIATRICS (2018)
Respiratory Management of the Patient With Duchenne Muscular Dystrophy
Daniel W. Sheehan et al.
PEDIATRICS (2018)
Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis
Erik Landfeldt et al.
PHARMACOECONOMICS (2017)
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
S. Ryder et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
HEALTH CARE UTILIZATION AND COSTS FOR CHILDREN AND ADULTS WITH DUCHENNE MUSCULAR DYSTROPHY
Lucinda J. Teoh et al.
MUSCLE & NERVE (2016)
Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy
Robert C. Griggs et al.
NEUROLOGY (2016)
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy Report of the Guideline Development Subcommittee of the American Academy of Neurology
David Gloss et al.
NEUROLOGY (2016)
The experiences of patients with Duchenne muscular dystrophy in facing and learning about their clinical conditions
Haruo Fujino et al.
INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING (2016)
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study
Luca Bello et al.
NEUROLOGY (2015)
TREATMENT PATTERNS, RESOURCE UTILIZATION AND COSTS IN MUSCULAR DYSTROPHY PATIENTS: ANALYSIS USING ADMINISTRATIVE CLAIMS DATA
M. Stott-Miller et al.
VALUE IN HEALTH (2015)
Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada
Eric I. Benchimol et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
The burden of Duchenne muscular dystrophy An international, cross-sectional study
Erik Landfeldt et al.
NEUROLOGY (2014)
Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany
Olivia Schreiber-Katz et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
The cooperative international neuromuscular research group duchenne natural history studya longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used
Craig M. McDonald et al.
MUSCLE & NERVE (2013)
Electronic Medical Records for Discovery Research in Rheumatoid Arthritis
Katherine P. Liao et al.
ARTHRITIS CARE & RESEARCH (2010)
Respiratory surveillance of patients with Duchenne and Becker muscular dystrophy
Virginia Spehrs-Ciaffi et al.
JOURNAL OF PEDIATRIC REHABILITATION MEDICINE (2009)
分享论文
